ArticleJournal of neurology2020

A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis.

Eleonora Tavazzi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.